251 related articles for article (PubMed ID: 31496684)
41. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
42. Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations.
Giuliano E; Paolino D; Fresta M; Cosco D
Medicines (Basel); 2018 Dec; 6(1):. PubMed ID: 30597953
[TBL] [Abstract][Full Text] [Related]
43. 7-acetoxycoumarin dimer-incorporated and folate-decorated liposomes: photoresponsive release and in vitro targeting and efficacy.
Seo HJ; Kim JC
Bioconjug Chem; 2014 Mar; 25(3):533-42. PubMed ID: 24533729
[TBL] [Abstract][Full Text] [Related]
44. P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
Chi BH; Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chang IH
J Korean Med Sci; 2015 Mar; 30(3):308-16. PubMed ID: 25729255
[TBL] [Abstract][Full Text] [Related]
45. Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration.
Zhang X; Hu X; Xie Y; Xie L; Chen X; Peng M; Li D; Deng J; Xiao D; Yang X
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764495
[TBL] [Abstract][Full Text] [Related]
46. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
Gupta Y; Jain A; Jain P; Jain SK
J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
[TBL] [Abstract][Full Text] [Related]
47. Liposome-Encapsulated Bacillus Calmette-Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo via Induction of AMP-Activated Protein Kinase.
Whang YM; Yoon DH; Hwang GY; Yoon H; Park SI; Choi YW; Chang IH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33302414
[TBL] [Abstract][Full Text] [Related]
48. Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation.
Chung CK; García-Couce J; Campos Y; Kralisch D; Bierau K; Chan A; Ossendorp F; Cruz LJ
Molecules; 2020 May; 25(9):. PubMed ID: 32397328
[TBL] [Abstract][Full Text] [Related]
49. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
[TBL] [Abstract][Full Text] [Related]
50. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
[TBL] [Abstract][Full Text] [Related]
51. Poloxamer 407 Based Gel Formulations for Transungual Delivery of Hydrophobic Drugs: Selection and Optimization of Potential Additives.
Ullah KH; Raza F; Munawar SM; Sohail M; Zafar H; Zafar MI; Ur-Rehman T
Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641190
[TBL] [Abstract][Full Text] [Related]
52. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
53. Optimization of a floating poloxamer 407-based hydrogel using the Box-Behnken design: in vitro characterization and in vivo buoyancy evaluation for intravesical instillation.
Goo YT; Yang HM; Kim CH; Kim MS; Kim HK; Chang IH; Choi YW
Eur J Pharm Sci; 2021 Aug; 163():105885. PubMed ID: 34022408
[TBL] [Abstract][Full Text] [Related]
54. An ATF
Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X
Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399
[No Abstract] [Full Text] [Related]
55. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
Xiao Z; Mak A; Koch K; Moore RB
BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
[TBL] [Abstract][Full Text] [Related]
56. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
Chen H; Ahn R; Van den Bossche J; Thompson DH; O'Halloran TV
Mol Cancer Ther; 2009 Jul; 8(7):1955-63. PubMed ID: 19567824
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
58. Targeting folate receptors to treat invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Naughton JF; Cheng L; Low PS; Rothenbuhler R; Leamon CP; Parker N; Klein PJ; Vlahov IR; Reddy JA; Koch M; Murphy L; Fourez LM; Stewart JC; Knapp DW
Cancer Res; 2013 Jan; 73(2):875-84. PubMed ID: 23204225
[TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.
Ren L; Yang X; Zhao L; Zhang H; Wang J
Integr Cancer Ther; 2016 Mar; 15(1):80-6. PubMed ID: 26315609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
